Ryan Chauffe, DO
Interventional Cardiology · Lafayette, LANPI 1376741736
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,429 of the $9,115 with a category attached, or 81.5%. 36 manufacturers reported payments, led by Abiomed at 25.2% of the total. Reporting peaked in 2019 at $2,828 and has fallen 53.2% since, to $1,323 in 2025. That places this record below the midpoint for interventional cardiology clinicians in LA, where the typical reported total is $9,970.
Across 255 payments — averaging $35.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$2K
- Penumbra, Inc.$2K
- Johnson & Johnson$608
- Pfizer$516
- Medtronic$451
- Boston Scientific$446
- plus $3K from 30 others
Across 4 payments — averaging $1320.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cordis Corporation$5K
What the payments were for
- Travel & lodging$1,52117%
- Food & beverage$7,42982%
- Education$140%
- Entertainment$1502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 15 | $2,299 |
| Penumbra, Inc. | 8 | $1,570 |
| Johnson & Johnson | 50 | $608 |
| Pfizer | 30 | $516 |
| Medtronic(2 entities) | 16 | $451 |
| Boston Scientific | 9 | $446 |
| Shockwave Medical, Inc | 8 | $422 |
| Novartis | 22 | $268 |
| Abbott | 2 | $258 |
| E.r. Squibb & Sons, L.L.C. | 10 | $197 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $184 |
| Shimadzu Precision Instruments, Inc. | 1 | $150 |
| Recor Medical Inc | 1 | $149 |
| Kowa Pharmaceuticals America, Inc. | 9 | $146 |
| Asahi Intecc USA, Inc. | 6 | $141 |
| Merck | 8 | $141 |
| Stryker | 1 | $134 |
| Bard Peripheral Vascular, Inc. | 1 | $131 |
| AstraZeneca | 8 | $130 |
| Amgen | 6 | $124 |
| Boehringer Ingelheim | 6 | $109 |
| Kestra Medical Technology Services, Inc. | 4 | $103 |
| Lexicon Pharmaceuticals, Inc. | 3 | $54 |
| Sanofi-aventis U.S. LLC | 3 | $50 |
| Angiodynamics, Inc. | 3 | $46 |
| Cvrx, Inc. | 2 | $44 |
| Philips North America LLC | 2 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $35 |
| Heartflow, Inc. | 1 | $34 |
| Portola Pharmaceuticals, LLC | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Gilead | 2 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,965
- Indigo System$1,357
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$296
- CardioMEMS HF System$174
- TRINIAS$150
- Paradise Ultrasound Renal Denervation System$149
- LIMFLOW SYSTEM$134
- RESOLUTE ONYX$134
- LUTONIX$131
- FFR LINK$126
- SYMPLICITY G3$120
- Penumbra System$117
- ASAHI PTCA Guide Wire$108
- STINGRAY$102
How this compares
$9,115 in reported general payments places this provider in the 45th percentile of 171 interventional cardiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 247 | $211,635 |
| EntrestoSacubitril/Valsartan | 83 | $81,739 |
| JardianceEmpagliflozin | 69 | $61,830 |
| XareltoRivaroxaban | 51 | $48,177 |
| Repatha SureclickEvolocumab | 16 | $17,843 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $3,546 |
| Propafenone Hcl | 23 | $1,587 |
| Amlodipine Besylate | 140 | $1,211 |
| Metoprolol Succinate | 129 | $1,109 |
| Atorvastatin Calcium | 107 | $1,085 |
| ClopidogrelClopidogrel Bisulfate | 136 | $1,077 |
| Flecainide Acetate | 29 | $1,032 |
| Ranolazine ErRanolazine | 15 | $871 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 12 | $871 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 53 | $731 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $516 | $211,635247 claims |
| NovartisEntresto | $268 | $81,73983 claims |
| Boehringer IngelheimJardiance | $109 | $61,83069 claims |
| Johnson & JohnsonXarelto | $608 | $48,17751 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 171 interventional cardiology providers in Louisiana.
Other interventional cardiology in Lafayette
- Ankur LodhaLafayette$640K
- Agostino IngraldiLafayette$315K
- Louis SalvaggioLafayette$214K
- Eric ThomasseeLafayette$149K
- Amit AminLafayette$82K
- Raghotham PatlolaLafayette$76K
- Craig WalkerHouma$5M
- Denzil MoraesBaton Rouge$901K
- Rajan PatelNew Orleans$517K
- Steven BaileyShreveport$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.